Latest Articles

Publication Date
ScotRail commits to becoming Endometriosis Friendly Employer - RailStaff

ScotRail commits to becoming Endometriosis Friendly Employer RailStaff

Published: Oct. 25, 2024, 11:08 a.m.
ENDOSURE Develops 30-Minute Non-Invasive Test for Endometriosis Diagnosis - Femtech Insider

ENDOSURE Develops 30-Minute Non-Invasive Test for Endometriosis Diagnosis Femtech Insider

Published: Oct. 25, 2024, 11:03 a.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - The Week

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation The Week

Published: Oct. 25, 2024, 5:28 a.m.
HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward - Devdiscourse

HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward Devdiscourse

Published: Oct. 25, 2024, 5:14 a.m.
Five Things You Need To Know About Endometriosis - Yale School of Medicine

Five Things You Need To Know About Endometriosis Yale School of Medicine

Published: Oct. 24, 2024, 10:23 p.m.
Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma

Hope Medicine touts favourable mid-stage data for endometriosis therapy FirstWord Pharma

Published: Oct. 24, 2024, 9:31 p.m.
For Daisy Ridley, a Plant-Based Diet Is Key to Managing Her PCOS, Endometriosis, and Graves’ Disease - VegNews

For Daisy Ridley, a Plant-Based Diet Is Key to Managing Her PCOS, Endometriosis, and Graves’ Disease VegNews

Published: Oct. 24, 2024, 9:30 p.m.
Son of Endometriosis Patient Running NYC Marathon to Honor His Mom and Bring Awareness to the Disease - Endometriosis Foundation of America - The Blossom

Son of Endometriosis Patient Running NYC Marathon to Honor His Mom and Bring Awareness to the Disease Endometriosis Foundation of America - The Blossom

Published: Oct. 24, 2024, 7:10 p.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire

Published: Oct. 24, 2024, 12:08 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!